Search Results

There are 16574 results for: content related to: A systematic review and mixed treatment comparison of pharmacological interventions for the treatment of obesity

  1. An assessment of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mechanism of action

    Obesity Reviews

    Volume 1, Issue 2, October 2000, Pages: 127–139, E. Nisoli and M. O. Carruba

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1467-789x.2000.00020.x

  2. You have free access to this content
    NPY5R Antagonism Does Not Augment the Weight Loss Efficacy of Orlistat or Sibutramine

    Obesity

    Volume 15, Issue 8, August 2007, Pages: 2027–2042, Ngozi Erondu, Carol Addy, Kaifeng Lu, Madhuja Mallick, Bret Musser, Ira Gantz, Joseph Proietto, Arne Astrup, Søren Toubro, Aila M. Rissannen, Serena Tonstad, William G. Haynes, Keith M. Gottesdiener, Keith D. Kaufman, John M. Amatruda and Steven B. Heymsfield

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2007.242

  3. The effect of antiobesity drugs on waist circumference: a mixed treatment comparison

    Diabetes, Obesity and Metabolism

    Volume 16, Issue 3, March 2014, Pages: 237–247, M. Chilton, A. Dunkley, P. Carter, M. J. Davies, K. Khunti and L. J. Gray

    Version of Record online : 15 SEP 2013, DOI: 10.1111/dom.12198

  4. You have free access to this content
    The Safety Profiles of Orlistat and Sibutramine: Results of Prescription-Event Monitoring Studies in England

    Obesity

    Volume 15, Issue 11, November 2007, Pages: 2712–2722, Michael J. Perrio, Lynda V. Wilton and Saad A. W. Shakir

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2007.323

  5. Effects of Clopidogrel on the Pharmacokinetics of Sibutramine and Its Active Metabolites

    The Journal of Clinical Pharmacology

    Volume 51, Issue 12, December 2011, Pages: 1704–1711, Jung-Woo Bae, Choon-Gon Jang and Seok-Young Lee

    Version of Record online : 12 MAR 2013, DOI: 10.1177/0091270010388651

  6. Association of CYP2B6, CYP3A5, and CYP2C19 Genetic Polymorphisms With Sibutramine Pharmacokinetics in Healthy Korean Subjects

    Clinical Pharmacology & Therapeutics

    Volume 86, Issue 5, November 2009, Pages: 511–518, KA Kim, WK Song and JY Park

    Version of Record online : 19 AUG 2009, DOI: 10.1038/clpt.2009.145

  7. Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success

    Diabetes, Obesity and Metabolism

    Volume 10, Issue 6, June 2008, Pages: 498–505, K. Elfhag, N. Finer and S. Rössner

    Version of Record online : 26 JUN 2007, DOI: 10.1111/j.1463-1326.2007.00740.x

  8. You have free access to this content
    Effects of Sibutramine Plus Orlistat in Obese Women Following 1 Year of Treatment by Sibutramine Alone: A Placebo-Controlled Trial

    Obesity Research

    Volume 8, Issue 6, September 2000, Pages: 431–437, Thomas A. Wadden, Robert I. Berkowitz, Leslie G. Womble, David B. Sarwer, Marjorie E. Arnold and Carrie M. Steinberg

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2000.53

  9. You have free access to this content
    Sibutramine Plus Meal Replacement Therapy for Body Weight Loss and Maintenance in Obese Patients

    Obesity

    Volume 15, Issue 6, June 2007, Pages: 1464–1472, James L. Early, Caroline M. Apovian, Louis J. Aronne, Madelyn H. Fernstrom, Arthur Frank, Frank L. Greenway, David Heber, Robert F. Kushner, Kristine M. Cwik, Julia K. Walch, Ann C. Hewkin and Vicky Blakesley

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2007.175

  10. You have free access to this content
    Effects of Sibutramine on Resting Metabolic Rate and Weight Loss in Overweight Women

    Obesity Research

    Volume 6, Issue 2, March 1998, Pages: 115–121, Helen M. Seagle, Dan H. Bessesen and Dr. James O. Hill

    Version of Record online : 6 SEP 2012, DOI: 10.1002/j.1550-8528.1998.tb00324.x

  11. Sibutramine usage in New Zealand: an analysis of prescription data by the Intensive Medicines Monitoring Programme

    Pharmacoepidemiology and Drug Safety

    Volume 16, Issue 11, November 2007, Pages: 1217–1226, Geraldine R. Hill, Janelle Ashton and Mira Harrison-Woolrych

    Version of Record online : 30 JUL 2007, DOI: 10.1002/pds.1447

  12. You have free access to this content
    Peripheral Mechanisms of Sibutramine Involving Proximal Gastric Motility in Dogs

    Obesity

    Volume 14, Issue 8, August 2006, Pages: 1363–1370, Junying Xu and Jiande D.Z. Chen

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2006.154

  13. You have free access to this content
    Sibutramine Produces Dose-Related Weight Loss

    Obesity Research

    Volume 7, Issue 2, March 1999, Pages: 189–198, George A. Bray, George L. Blackburn, James M. Ferguson, Frank L. Greenway, Adesh K. Jain, Carl M. Mendel, Joseph Mendels, Donna H. Ryan, Sherwyn L. Schwartz, Monte L. Scheinbaum and Timothy B. Seaton

    Version of Record online : 6 SEP 2012, DOI: 10.1002/j.1550-8528.1999.tb00701.x

  14. You have free access to this content
    Influence of Sibutramine on Energy Expenditure in African American Women

    Obesity Research

    Volume 9, Issue 4, April 2001, Pages: 251–256, Raymond D. Starling, Xiaolan Liu and Dennis H. Sullivan

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2001.29

  15. Role of sibutramine in the treatment of obese Type 2 diabetic patients receiving sulphonylurea therapy

    Diabetic Medicine

    Volume 19, Issue 2, February 2002, Pages: 119–124, M. Serrano-Rios, N. Melchionda and * E. Moreno-Carretero

    Version of Record online : 7 MAR 2002, DOI: 10.1046/j.1464-5491.2002.00655.x

  16. You have free access to this content
    5-HT1A Activation Counteracts Cardiovascular But Not Hypophagic Effects of Sibutramine in Rats

    Obesity

    Volume 17, Issue 3, March 2009, Pages: 467–473, Gerard H. Thomas, Adam J. Babbs, Rosemary E. Chatfield, Thomas M. Krülle, Peter S. Widdowson, Daniel Provost and James G. McCormack

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2008.550

  17. You have free access to this content
    Six-Month Treatment of Obesity with Sibutramine 15 mg; A Double-Blind, Placebo-Controlled Monocenter Clinical Trial in a Hispanic Population

    Obesity Research

    Volume 8, Issue 1, January 2000, Pages: 71–82, Guillermina Elisa Martínez Cuellar, Alberto Martínez Ruiz, Maria Cristina Revilla Monsalve and Dr. Arturo Berber

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2000.10

  18. Effect of antiobesity medications in patients with type 2 diabetes mellitus

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 7, July 2009, Pages: 641–664, Souzana Choussein, Angeliki A. Makri, Constantinos C. Frangos, Eleni Th. Petridou and Stella S. Daskalopoulou

    Version of Record online : 18 FEB 2009, DOI: 10.1111/j.1463-1326.2008.01026.x

  19. Serotoninergic and Mixed Agents

    Medical Toxicology of Drug Abuse: Synthesized Chemicals and Psychoactive Plants

    Donald G. Barceloux, Pages: 255–274, 2012

    Published Online : 2 FEB 2012, DOI: 10.1002/9781118105955.ch14

  20. Proteome changes in rat plasma in response to sibutramine

    PROTEOMICS

    Volume 11, Issue 7, April 2011, Pages: 1300–1312, Jung-Won Choi, Jeong In Joo, Dong Hyun Kim, Xia Wang, Tae Seok Oh, Duk Kwon Choi and Jong Won Yun

    Version of Record online : 17 FEB 2011, DOI: 10.1002/pmic.201000664